ABSTRACT
RÉSUMÉ CONTEXTE: La modification hypothèse oxydative de l'athérosclérose prédit que des lipoprotéines de faible densité-cholestérol (LDL-C), l'oxydation est un événement précoce dans l'athérosclérose et que l'oxydation du LDL-C contribue à l'athérogenèse. Objectif: déterminer un lien éventuel entre le plasma et de la peroxydation lipidique total antioxidant status (TAS) et les dyslipidemic nigérian patients hypertendus à haut risque de maladie coronarienne.

MÉTHODES: Les groupes d'étude comprenait 58 hypertendus adultes Nigérians dont le plasma à jeun de cholestérol total (CT) ont été> 5.5mmol / L et avec un risque élevé de maladie coronarienne (CHD) de lipides c'est-à-dire la fraction «le taux de cholestérol des lipoprotéines de haute densité pour le cholestérol total" (HDL-C/TC) <0,13 ont été retenus pour l'étude. Les groupes de contrôle comprenant 58 adultes hypertendus non avec les Nigérians (HDL-C/TC)> 0,30. RÉSULTATS: La moyenne ± TAS niveau (1,02 ± 0,15 mmol / L trolox) pour les hommes et de (0,99 ± 0,17 mmol / L) pour les femmes a été sensiblement réduit (p <0,05) par rapport aux contrôles, mais (MDA) niveau
 (5,15 ± 
INTRODUCTION
The activities of free radicals in many age-related diseases have long been of interest, and there is substantial evidence linking diabetes, cancer, and atherosclerosis to free radical-induced alterations.
1, 2 With regard to atherosclerosis, evidence for a free radical contribution to the disease was advanced by Parthasarathy and co-workers who proposed the oxidative modification hypothesis for atherosclerosis. 3 Although the aetiology of atherosclerosis has been the subject of intense research for the last several decades, our understanding of the role of the major risk factors, such as lipoprotein, in the development of atherosclerotic lesions was quite limited until recently. 3 The mechanism by which increased lowdensity lipoproteins-cholesterol (LDL-C) levels cause increased fatty deposits on the cells lining the arterial wall, thereby forming the earliest lesion of the fatty streak, has been of major interest. 4 Recent investigations have produced cogent evidence that oxidatively modified LDLs play a major role in the formation of the fatty streaks. 4 A major clue to the identity of the missing link was uncovered by several recent studies on the uptake of oxidized LDLs by monocytes and macrophages, which eventually convert to lipid-laden foam cells. 4, 5 Steinberg et al. demonstrated that modification of LDL molecules takes place only in the presence of metals and can be suppressed by antioxidants, strongly implicating the involvement of free radical-mediated peroxidative reactions. 7 Triau et al showed that incubating oxidized LDLs with endothelial cells stimulates production of prostaglandins, thus making oxidatively modified LDL more active than native LDL in promoting platelet aggregation. 8, 9 These stimulating effects of oxidatively modified LDL seem to be specific to the oxidation because neither native LDL nor acetylated LDL affected prostaglandin synthesis. 8 Recently, Morel et al showed that oxidatively damaged low-density lipoproteins found in streptozotocininduced diabetic rats were cytotoxic to cultured fibroblasts. 9 The addition of antioxidants such as vitamin E or probucol, which also lowers cholesterol, attenuated the extent of the toxicity. 9 The therapeutic efficacy of antioxidant treatment of atherosclerosis has not been pursued vigorously, but there are some indications that LDL isolated from patients treated for hypercholesterolemia with probucol or vitamin E is more resistant to oxidative alterations induced by metal ions. 10 Experiments with the Watanabe rabbit, which lacks LDL receptors, found that probucol decreases the rate of atherosclerotic progression by acting as an antioxidant.
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The above finding was confirmed in humans, which provides strong evidence for a causal relationship between free radicals, lipid peroxidation, and atherosclerosis. 12 These investigators demonstrated a close association between the susceptibility to LDL oxidation and coronary atherosclerosis in male subjects. Other studies further support the relationship between lipid peroxidation and oxidative processes as being important factors in atherogenesis. 13 The protective efficiency of antioxidants in hypercholesterolemic patients would depend on the balance between free radicals and the availability of antioxidants themselves.
14 However the relationship between hypertension and dyslipidemia has also been demonstrated by various investigators from Nigeria, it has been established that dyslipidemia and hypertension are independent risk factors of coronary heart disease. 15, 16 Hence the present study was undertaken to evaluate a correlation between malonyldialdehyde (MDA), which is a marker of lipid peroxidation and total antioxidant status in plasma of dyslipidemic and hypertensive adult Nigerians with high risk of Coronary Heart Disease
SUBJECTS, MATERIALS AND METHODS
The study was carried out at the Ladoke Akintola University of Technology Teaching Hospital, Osogbo between the months of January 2005 and March 2006. The study population compriseD 58 hypertensive patients (Systolic blood pressure =140mmhg and diastolic = 90mmhg), whose plasma total cholesterol level was =5.5mmol/L and between the ages of 30-70 years who were not on any drugs with high risk coronary heart disease (CHD) lipid fraction, that is the ratio of high density lipoprotein cholesterol to total cholesterol (HDL-C/TC) = 0.13 were selected for the study. The study was approved by the college and hospital ethics committee. Patients who were diabetics, have any form of cancer, renal pathology, liver disease, lung disease, neurodegenerative disease, inflammatory disease, infectious disease and cardiovascular disease were excluded from the study. Formal consent was obtained from the patients after explaining to them the benefit of the study before commencing the study. Fifty-eight consenting healthy subjects between the ages of 30-70years whose plasma cholesterol is = 3.5 mmol/L, with (HDL-C/ TC) = 0.30 was used as controls. After an overnight fast, 10ml of venous blood was collected at the antecubical fossa in sitting position without stasis into lithium heparinized bottle. Plasma was obtained after centrifugation at 3500r.p.m for 10 minutes and immediately stored at -20 o C until they were analysed.
Total plasma cholesterol and triglycerides were determined enzymatically using kits from Randox laboratory Ireland UK. 17, 18 HDL (high-density lipoprotein) -cholesterol was measured (when triglycerides were <4 mmol/L) after low-density lipoproteins, very low density lipoprotein) (LDL, VLDL) and chylomicron fractions were precipitated quantitatively by addition of phosphotungstic acid in the presence of magnesium ions. After centrifugation, the cholesterol concentration in the HDL (high density lipoprotein) fraction, which remained in the supernatant, was analyzed. 19 Quality control was ensured by the use of control materials from Randox laboratory and Human Company of Germany. LDL-cholesterol was calculated using Friedwald formula (LDL Cholesterol=Total Cholesterol -(Triglyceride/5 + HDL Cholesterol). 20 The cardiovascular risk ratio was calculated from the values of lipids profile obtained. 21 Measurement of secondary products of lipid peroxidation such as malonyldialdehyde (MDA) was employed to assess oxidative stress in this study. Malonyldialdehyde (MDA) was estimated according to the method of Satoh. 22 Measurement of total antioxidant status in the plasma was performed using a commercial kit from Randox Laboratories (Randox Laboratories Ltd, Diamond Road, Crumlin, Co. Antrim, Ireland). 23 The assay was calibrated using 6-hydroxy-2, 5, 8-tetra-methylchroman-2-carboxylic acid (trolox). The results were expressed as mmo/L of trolox equivalent.
Statistical analysis:
All values were entered into EPI INFO (version 6.4a database). Values are expressed as mean ± SD, the statistical significance of the mean differences between groups was assessed by Student's t-test. Method of correlation analysis (PEARSON) was also used to determine the degree of association between variable of interest. Valve of p< 0.05 was taken as a measure statistical significance.
RESULTS
The study was carried out with equal numbers of subjects (n=58) and controls (n=58), males were 30 and females 28 giving a male: female ratio of 1:0.9. The anthropometric data for the subjects and controls are presented in Table 1 . The mean ages ±SD of the subjects and controls was not significantly different in both sexes. However, the body mass index was significantly higher (27. HDL Cholesterol showed an inverse correlation with MDA (r=-0.41, p< 0.01) and (r=-0.45, p< 0.01) respectively in male and in female hypertensive subjects. However a direct correlation between HDL-C/MDA(r=0.43, p< 0.01) and (r=0.48, p< 0.01) respectively in male and in female hypertensive subjects.
Both male and female hypertensive subjects with high risk coronary heart disease (CHD) lipid fraction, had an inverse correlation with MDA (r=-0.39, p< 0.05) and (r=-0.31, p< 0.05) respectively. However a direct correlation with TAS (r=0.27, p< 0.05) and (r=0.45, p< 0.01) respectively for male and female hypertensive subjects.
DISCUSSION
Atherosclerosis is a major source of morbidity and mortality in the developed world, currently a problem of the developed world; however it is gradually becoming one of the major health problems in third world countries like Nigeria, especially among the upper class due to the influence of foreign culture. 24 In this study, we observed that hypertensive and dyslipidemia patients with high risk CHD have increased body weight and BMI in both sexes when compared to the controls. We also observed a significant increased in the plasma MDA level which serves as the marker of lipid peroxidation in these category patients. This finding is similar to the study of Prasad and Kalra; 25 they reported an increased in the blood MDA concentration in rabbits with a high cholesterol diet. We also observed a direct correlation between plasma concentration of MDA and plasma concentration of triglyceride, total cholesterol, LDLcholesterol, systolic BP and diastolic BP and on the other hand an inverse correlation with HDL cholesterol and HDL-Chol/TC ratios in both sexes. These finding is similar to the finding of Das S et al among hypercholesterolemia patients of Asian origin. 26 The total antioxidant status in the plasma of patients in this study with dyslipidemia was significantly reduced in both sexes in comparison with the control subjects; sex did not show a particular pattern in this case. Plasma TAS have inverse correlation with plasma concentration of triglyceride, total cholesterol, LDL-cholesterol, systolic BP and diastolic BP and on the other hand direct correlation with HDL cholesterol and HDL Chol/TC ratios in both sexes. In healthy condition a balance exists between free-radical generation and antioxidant defense system which prevents occurrence of diseases.
1,2 Our finding in this study shows that dyslipdemia would shifts the balance in favour of free-radical generation, which may leads to oxidative tissue damage and thus sets the stage for atherosclerosis. Since dyslipidemia and lipid peroxidation both directly relate to the severity of atherosclerosis, 3 elimination of free radicals in the plasma before they can be taken up by the peripheral tissues might reduce the process of atherosclerosis in these categories of patients.
Enstrom et al. in their study showed an inverse relationship between vitamin C intake and overall cardiovascular mortality in a population study involving 11,348 adults. 27 Similarly, Schwertner et al. shown in their study on 877 men that serum bilirubin, an endogenous antioxidant had an inverse relationship with serum cholesterol, cigarettes smoked/day, systolic BP, serum triglyceride and fasting glucose. 28 Base on our discussion oxidative stress, arising as a result of an imbalance between free radical production and antioxidant deficiencies, is associated with damage to a wide range of molecular species, which includes lipids and lipoproteins. Dyslipidemia is 12 but at any given concentration of plasma cholesterol, there is variability in the occurrence of cardiovascular events, as it has been shown that the oxidative modification of LDL might be a crucially important step in the development of atherosclerotic plaque. 7 Studies have shown that antioxidant supplementation in healthy subjects or CAD patients can reduce levels of free radical damage produced and protect LDL-cholesterol against oxidation. 27 Large scale epidemiological studies have shown that low intake of antioxidants is associated with increased cardiovascular risk. 29 Limitations of our study lie in the weakness of parameters used for measurement of oxidative stress. TBARS is not the best available marker of lipid peroxidation and we have not included measures of red-cell antioxidant enzymes. Another weakness is the lack of data on dietary intake of our subjects during the study period. Nevertheless, accepting these limitations, our results show a reduction in plasma TAS and increase in MDA in hypertensive and dyslipidemic patients with high risk coronary heart disease.
CONCLUSION
Since dyslipidemia, hypertension and lipid peroxidation were directly relate to the severity of atherosclerosis, elimination of free radicals in the plasma before they can be taken up by the peripheral tissues might reduce or eliminate development atherosclerosis in these category of patients. In view of our present findings, a management strategy aimed at simultaneous controlling lipid peroxidation and increasing total antioxidant status in patients with dyslipidemic may be beneficial.
